WNT10A (Wnt Family Member 10A)
Overview
flowchart TD
WNT10A["WNT10A"] -->|"associated with"| Ectodermal_Dysplasia_Syndromes["Ectodermal Dysplasia Syndromes"]
WNT10A["WNT10A"] -->|"associated with"| Tooth_Agenesis["Tooth Agenesis"]
WNT10A["WNT10A"] -->|"associated with"| Glioblastoma["Glioblastoma"]
WNT10A["WNT10A"] -->|"participates in"| Ectodermal_Organogenesis["Ectodermal Organogenesis"]
WNT10A["WNT10A"] -->|"participates in"| Tissue_Regeneration["Tissue Regeneration"]
WNT10A["WNT10A"] -->|"associated with"| Selective_Tooth_Agenesis["Selective Tooth Agenesis"]
WNT10A["WNT10A"] -->|"associated with"| Hidradenitis_Suppurativa["Hidradenitis Suppurativa"]
WNT10A["WNT10A"] -->|"associated with"| Cleft_Lip_with_without_Cleft_P["Cleft Lip with/without Cleft Palate"]
WNT10A["WNT10A"] -->|"associated with"| Carcinogenesis["Carcinogenesis"]
WNT10A["WNT10A"] -->|"associated with"| Fibrosis["Fibrosis"]
style WNT10A fill:#4fc3f7,stroke:#333,color:#000
WNT10A is a member of the Wnt family of secreted signaling proteins, which are key morphogens regulating cell fate, proliferation, migration, and polarity during embryonic development and tissue homeostasis. The Wnt signaling pathway is evolutionarily conserved and plays essential roles in development, stem cell biology, and tissue regeneration. WNT10A, located on chromosome 2q35, is particularly important for epithelial-mesenchymal interactions during embryonic development and for maintaining adult tissue stem cell populations["@Clevers2007"][@MacDonald2009].
...WNT10A (Wnt Family Member 10A)
Overview
Mermaid diagram (expand to render)
WNT10A is a member of the Wnt family of secreted signaling proteins, which are key morphogens regulating cell fate, proliferation, migration, and polarity during embryonic development and tissue homeostasis. The Wnt signaling pathway is evolutionarily conserved and plays essential roles in development, stem cell biology, and tissue regeneration. WNT10A, located on chromosome 2q35, is particularly important for epithelial-mesenchymal interactions during embryonic development and for maintaining adult tissue stem cell populations["@Clevers2007"][@MacDonald2009].
Mutations in WNT10A cause a spectrum of congenital disorders known as Wntopathies, primarily affecting ectodermal derivatives including hair, teeth, nails, and skin. These disorders include ectodermal dysplasia type 9, Schöpf-Schulz-Passarge syndrome, and related conditions with autosomal recessive inheritance["@Adaimy2012"][@Niemann2014]. In addition to its well-established developmental roles, recent research has revealed important functions for WNT10A in neurodevelopment and neurodegeneration, making it relevant to understanding brain disorders including Alzheimer's and Parkinson's diseases["@Liu2015"][@Inestrosa2013].
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | WNT10A |
| Full Name | Wnt Family Member 10A |
| Chromosomal Location | 2q35 |
| NCBI Gene ID | 25480 |
| OMIM ID | 606228 |
| Ensembl ID | ENSG00000135925 |
| UniProt ID | Q9GZT5 |
| Encoded Protein | Wnt-10a protein |
| Protein Family | Wnt family of signaling proteins |
| Associated Diseases | Ectodermal dysplasia, Wntopathies, Alzheimer's disease, Parkinson's disease |
</div>
Structure and Function
Protein Structure
WNT10A is a secreted glycoprotein of approximately 421 amino acids with a molecular weight of about 46 kDa. The protein contains several distinctive structural features:
Signal peptide: The N-terminal signal peptide directs WNT10A to the secretory pathway, enabling its secretion from producing cells.
Wnt domain: The central region contains the conserved Wnt domain, characterized by:
- 22 conserved cysteine residues forming disulfide bonds
- A distinctive cysteine-knot fold providing structural stability
- N-linked glycosylation sites for proper folding and secretion
Lipid modification site: Like other Wnt proteins, WNT10A undergoes palmitoylation at a conserved cysteine residue, which is essential for its secretion and function. This modification is catalyzed by the enzyme Porcupine (PORCN).
Receptor binding regions: Surface regions that interact with Wnt receptors (Frizzled proteins) and co-receptors (LRP5/6).Secretion and Trafficking
Wnt protein secretion requires a specialized machinery:
Wntless (WLS): The WLS protein is essential for Wnt secretion. WNT10A binds to WLS in the endoplasmic reticulum, is transported through the secretory pathway, and is released at the plasma membrane[@Bafgi2018].
Porcupine-mediated acylation: The PORCN enzyme adds palmitoyl groups to WNT10A, enabling its association with lipid rafts and proper receptor interaction.
Extracellular transport: WNT10A can act in an autocrine or paracrine manner, diffusing through the extracellular matrix to reach target cells.
Gradient formation: WNT10A forms concentration gradients in tissues, with different concentrations specifying different cell fates during development.Signaling Pathways
Canonical Wnt/β-Catenin Pathway
WNT10A can activate the canonical Wnt pathway, which is the most well-characterized Wnt signaling cascade[@Clevers2007][@MacDonald2009]:
Receptor binding: WNT10A binds to Frizzled (FZD) receptors, which are seven-pass transmembrane proteins, along with LRP5/6 co-receptors.
Dishevelled activation: Receptor activation leads to recruitment and activation of Dishevelled (DVL) proteins, which become phosphorylated and cluster at the membrane.
β-catenin stabilization: Activated DVL inhibits the β-catenin destruction complex (containing GSK3β, APC, Axin), preventing β-catenin phosphorylation and degradation.
Nuclear translocation: Stabilized β-catenin accumulates in the cytoplasm and translocates to the nucleus.
Target gene activation: In the nucleus, β-catenin interacts with TCF/LEF transcription factors to activate expression of target genes, including:
- C-MYC: Cell proliferation
- Cyclin D1: Cell cycle progression
- AXIN2: Feedback regulation
- MMPs: Extracellular matrix remodeling
Non-Canonical Pathways
WNT10A also signals through non-canonical pathways that do not involve β-catenin[@Kimmel2000]:
Planar Cell Polarity (PCP) pathway:
- WNT10A activates Frizzled receptors without LRP co-receptors
- DVL activation leads to downstream signaling through Rho GTPases (Rac, Rho, Cdc42)
- Regulates cytoskeletal dynamics and cell polarity
- Important for tissue morphogenesis and neural tube closure
Wnt/Ca2+ pathway:
- Some Frizzled receptors can activate G-proteins leading to intracellular Ca2+ release
- Activates PKC (protein kinase C) and CaMKII (Ca2+/calmodulin-dependent protein kinase II)
- Regulates cell adhesion and migration
- Can have both positive and negative effects on canonical signaling
Rho GTPase regulation:
- WNT10A influences the activity of Rho family GTPases
- Controls cytoskeletal dynamics and cell movement
- Important for neuronal axon guidance
Biological Functions
Development
WNT10A plays critical roles in embryonic development[@Wong2012]:
Limb development:
- Regulates patterning of digits and joints
- Controls outgrowth and morphogenesis
- Essential for proper limb formation
Hair follicle formation:
- Initiates hair follicle morphogenesis
- Maintains hair follicle stem cell populations
- Regulates hair cycling in adults
Tooth development:
- Regulates tooth morphogenesis
- Controls enamel formation
- Important for dental lineage specification
Skin appendage formation:
- Regulates nail development
- Controls sweat gland formation
- Essential for epidermal differentiation
Stem Cell Biology
WNT10A is important for maintaining stem cell populations[@Reya2005]:
Epithelial stem cells:
- Maintains hair follicle stem cells
- Supports intestinal stem cell function
- Important for skin regeneration
Neural stem cells:
- Promotes neural progenitor proliferation
- Supports neurogenesis in specific brain regions
- May influence neural stem cell differentiation
Mesenchymal stem cells:
- Regulates osteoblast differentiation
- Controls chondrocyte maturation
- Important for bone and cartilage formation
Cancer stem cells:
- Implicated in tumor initiation and maintenance
- Contributes to chemotherapy resistance
- Promotes metastasis in some cancers
Role in Neurobiology
Neurodevelopment
WNT10A has important functions in nervous system development[@Barolo2012][@Shimogawa2014]:
Neural tube patterning:
- Regulates dorsal-ventral patterning of the neural tube
- Controls cell fate specification in the developing CNS
- Important for proper brain morphology
Neuronal differentiation:
- Promotes neuronal differentiation from neural progenitors
- Regulates specific neuronal subtype specification
- Influences cortical development
Axon guidance:
- WNT10A acts as an axon guidance cue
- Attracts or repels growing axons
- Important for proper circuit formation
Synapse formation:
- Regulates synaptic plasticity
- Controls presynaptic assembly
- Important for postsynaptic differentiation
Synaptic Function
WNT10A plays roles in synaptic function and plasticity[@Cerpa2015]:
Synapse formation:
- Promotes excitatory synapse formation
- Regulates postsynaptic density organization
- Controls neurotransmitter receptor trafficking
Synaptic plasticity:
- Modulates long-term potentiation (LTP)
- Influences long-term depression (LTD)
- Important for learning and memory
Presynaptic function:
- Regulates vesicle release probability
- Controls presynaptic active zone organization
- Influences neurotransmitter release
Role in Neurodegeneration
Alzheimer's Disease
WNT10A and Wnt signaling more broadly are implicated in Alzheimer's disease pathogenesis[@Inestrosa2012][@Inestrosa2013][@Zhang2015][@Palomer2019]:
Amyloid-beta effects on Wnt signaling:
- Aβ oligomers inhibit Wnt signaling
- Disrupts synaptic plasticity mechanisms
- Contributes to cognitive deficits
Tau pathology interaction:
- Wnt/β-catenin signaling can modulate tau phosphorylation
- GSK3β (a component of both pathways) links these pathways
- Bidirectional crosstalk exists
Synaptic dysfunction:
- Wnt signaling is essential for synaptic maintenance
- Aβ-induced Wnt disruption contributes to synapse loss
- Rescue of Wnt signaling may protect synapses
Neuroinflammation:
- Wnt signaling modulates microglial activation
- Inflammatory cytokines can inhibit Wnt signaling
- Creates feedforward loop of dysfunction
Therapeutic potential:
- Wnt agonists may protect against Aβ toxicity
- GSK3β inhibitors (as Wnt modulators) show promise
- Gene therapy approaches are being explored
Parkinson's Disease
WNT10A and Wnt pathway dysregulation are also implicated in PD[@L'Episcopo2019]:
Dopaminergic neuron development:
- Wnt signaling is essential for proper dopaminergic neuron development
- Disruption may contribute to developmental vulnerabilities
α-Synuclein pathology:
- Wnt signaling can modulate α-synuclein aggregation
- Pathological α-Syn may disrupt Wnt function
Mitochondrial function:
- Wnt signaling influences mitochondrial biogenesis
- Dysregulation may contribute to energy deficits in PD
Neuroinflammation:
- Similar to AD, inflammatory pathways intersect with Wnt signaling
Therapeutic targeting:
- Wnt pathway modulators are being investigated
- Targeting microRNA regulation of Wnt is an emerging approach
Other Neurodegenerative Conditions
Amyotrophic Lateral Sclerosis (ALS):
- Wnt signaling alterations in motor neurons
- May contribute to disease progression
Multiple Sclerosis:
- Demyelination affects Wnt signaling in oligodendrocytes
- Wnt modulation may promote remyelination
Brain aging:
- Wnt signaling declines with age
- May contribute to age-related cognitive decline
Expression Patterns
Tissue Distribution
WNT10A shows specific expression patterns:
- High expression: Developing limbs, hair follicles, teeth, skin
- Moderate expression: Brain (developing and adult), gastrointestinal tract
- Low expression: Most adult tissues with stem cell populations
Brain Expression
In the nervous system:
Developmental expression:
- High expression during embryonic brain development
- Specific expression in ventricular zones
- Patterns correspond to neurogenic regions
Adult expression:
- Persists in specific brain regions
- Expression in hippocampus (neurogenic niche)
- Present in cortex and cerebellum
Cellular localization:
- Expressed in neurons and glia
- Secreted by specific neuronal populations
- Can be detected in cerebrospinal fluid
Therapeutic Implications
Targeting Wnt Signaling
Modulating Wnt signaling has therapeutic potential[@Kahn2014]:
Wnt agonists:
- Wnt10A mimetics for tissue repair
- Small molecule activators of Wnt pathway
- Gene therapy approaches
Wnt antagonists:
- Useful in cancer contexts
- Antibodies against Wnt ligands
- Frizzled receptor inhibitors
GSK3β inhibitors:
- Activate canonical Wnt pathway
- Have been tested in clinical trials
- Brain-penetrant versions in development
Porcupine inhibitors:
- Block Wnt secretion
- Useful in cancer therapy
Clinical Applications
Potential therapeutic uses include:
Regenerative medicine:
- Promoting hair follicle regeneration
- Supporting neural stem cell function
- Enhancing tissue repair
Neurodegenerative disease:
- Protecting neurons from degeneration
- Promoting synaptic function
- Supporting neurogenesis
Cancer therapy:
- Targeting cancer stem cells
- Blocking tumor progression
- Enhancing chemotherapy sensitivity
Interactions and Pathways
Receptor Interactions
| Receptor | Pathway | Function |
|----------|---------|----------|
| Frizzled (FZD1-10) | Canonical/Non-canonical | Primary Wnt receptors |
| LRP5/6 | Canonical | Co-receptors for β-catenin pathway |
| ROR1/2 | Non-canonical | Alternative receptors |
| Ryk | Non-canonical | Axon guidance receptor |
Key Signaling Components
Positive regulators:
- β-catenin (CTNNB1)
- Dishevelled (DVL)
- LRP5/6
- TCF/LEF
Negative regulators:
- GSK3β
- APC
- Axin
- Dickkopf (DKK) family
See Also
- [Wnt Signaling](/mechanisms/wnt-signaling)
- [Ectodermal Dysplasia](/diseases/ectodermal-dysplasia)
- [Planar Cell Polarity](/mechanisms/planar-cell-polarity)
- [Neurogenesis](/mechanisms/neurogenesis)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Stem Cells](/entities/stem-cells)
- [GSK3 Beta](/proteins/gsk3-beta)
External Links
- [Ensembl: ENSG00000135925](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000135925)
- [NCBI Gene: WNT10A](https://www.ncbi.nlm.nih.gov/gene/25480)
- [GeneCards: WNT10A](https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT10A)
- [OMIM: WNT10A](https://omim.org/search?search=WNT10A)
- [UniProt: Q9GZT5](https://www.uniprot.org/uniprot/Q9GZT5)
- [PubMed: WNT10A Research](https://pubmed.ncbi.nlm.nih.gov/?term=WNT10A+neurodegeneration)
References
[Clevers H, et al., Wnt/beta-catenin signaling and disease (2007)](https://pubmed.ncbi.nlm.nih.gov/17693254/)
[Adaimy L, et al., WNT10A mutation in ectodermal dysplasia (2012)](https://pubmed.ncbi.nlm.nih.gov/21992450/)
[Liu Y, et al., Wnt signaling in neurodegeneration (2015)](https://pubmed.ncbi.nlm.nih.gov/26264563/)
[MacDonald BT, et al., Wnt/beta-catenin signaling (2009)](https://pubmed.ncbi.nlm.nih.gov/19686688/)
[Kimmel AR, et al., Regulation of Wnt signaling by CK2 (2000)](https://pubmed.ncbi.nlm.nih.gov/10642527/)
[Wong YC, et al., Wnt signaling in hair follicle development (2012)](https://pubmed.ncbi.nlm.nih.gov/22821745/)
[Reya T, et al., Stem cells, cancer, and cancer stem cells (2005)](https://pubmed.ncbi.nlm.nih.gov/15885114/)
[Niemann S, et al., WNT10A mutations cause ectodermal dysplasias (2014)](https://pubmed.ncbi.nlm.nih.gov/24653033/)
[Inestrosa NC, et al., Wnt signaling in Alzheimer's disease (2013)](https://pubmed.ncbi.nlm.nih.gov/23775507/)
[Wend P, et al., Wnt target genes in colorectal cancer (2013)](https://pubmed.ncbi.nlm.nih.gov/24092756/)
[Bänfgi D, et al., Wntless in Wnt secretion (2018)](https://pubmed.ncbi.nlm.nih.gov/28686847/)
[Kahn M, et al., Can we safely target the Wnt pathway (2014)](https://pubmed.ncbi.nlm.nih.gov/25065775/)
[Inestrosa NC, et al., Wnt signaling in brain development (2012)](https://pubmed.ncbi.nlm.nih.gov/22470317/)
[Barolo S, et al., Wnt signaling in neural development (2012)](https://pubmed.ncbi.nlm.nih.gov/22988459/)
[Shimogawa TK, et al., Wnt signaling and neural circuit formation (2014)](https://pubmed.ncbi.nlm.nih.gov/25231535/)
[Zhang Z, et al., Wnt/beta-catenin in Alzheimer's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/26272173/)
[Palomer E, et al., Wnt signaling dysregulation in AD (2019)](https://pubmed.ncbi.nlm.nih.gov/31849650/)
[L'Episcopo F, et al., Wnt signaling in Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31197111/)
[Cerpa W, et al., Wnt signaling in synaptic plasticity (2015)](https://pubmed.ncbi.nlm.nih.gov/26621245/)
[Arceo N, et al., Wnt10A in neural stem cells (2021)](https://pubmed.ncbi.nlm.nih.gov/34059043/)